The Encephalitis Society are seeking an academic institution to host the 2019 Encephalitis Society PhD Fellowship. Deadline: Monday, December 31, 2018
Emgality® (galcanezumab) Receives European Commission Approval for the Prophylaxis of Migraine in Adults
New migraine treatment from Lilly receives approval from European Commission
Meeting on Abeta Oligomers in Alzheimer’s Disease (AD) and Other Misfolded Proteins in AD and Neurodegenerative Diseases
Industry news from AC Immune SA
28th Alzheimer Europe Conference: Making dementia a European priority – Conference Highlights
Highlights from the Barcelona meeting
Biogen Advances Research to Improve Outcomes for Patients with Multiple Sclerosis
News from Biogen
Europe’s only medical cannabis e-learning platform announces the UK as its first learning centre launch
Free and independent platform launched
APPG on ABI launches report on acquired brain injury and neurorehabilitation
APPG on ABI launches report on acquired brain injury and neurorehabilitation
New clinical practice data confirms clinical effectiveness of Zebinix® (eslicarbazepine acetate) monotherapy for focal-onset epilepsy in adults
New clinical practice data on Zebinix® (eslicarbazepine acetate) monotherapy for focal-onset epilepsy in adults
Spinraza® ▼ (nusinersen) Interim Data demonstrate Benefits in Treating Presymptomatic Infants with Spinal Muscular Atrophy
Spinraza® ▼ (nusinersen) Interim Data from Phase 2 Trial, NURTURE, Presented at Annual Congress of the World Muscle Society Demonstrate Benefits in Treating Presymptomatic Infants with Spinal Muscular Atrophy